Compare CVS Health Corp (CVS) vs First Citizens BancShares Inc (FCNCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs First Citizens BancShares Inc — how do they compare? CVS Health Corp trades at $86.16 (market cap $112.29B), while First Citizens BancShares Inc trades at $2,068.39 (market cap $22.94B). The key difference: CVS Health Corp is far larger — about 4.9× First Citizens BancShares Inc's market cap, and CVS Health Corp pays the higher dividend (3.03%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and First Citizens BancShares Inc for 29 Days on average.
| CVS | FCNCA | |
|---|---|---|
Market Cap | $112.29B | $22.94B |
Volume | 7,763,676 | 91,668 |
Sector | Health | Sector/Thematic |
52-Week High | $110.60 | $2.29K |
52-Week Low | $70.08 | $1.64K |
Typical Hold Time | 83 Days | 29 Days |
Enterprise Value | $174.64B | — |
Dividend Yield | 3.03% | 0.41% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, down 0.17% on the day, with a bearish technical signal and neutral oscillators. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $2.58 exceeding the $1.85 estimate. Revenue grew to $402.07B in 2025, though net income margin compressed to 1.18%. Recent news highlights Aetna's 2027 Medicare plan updates and a quarterly dividend declaration.
CVS presents a mixed outlook with solid revenue growth and analyst bullishness (85% buy ratings, $111.20 consensus target) offset by profitability pressures and a bearish technical trend. Key risks include reimbursement pressure and ongoing legal investigations, but the stock offers value with a low P/S of 0.27 and dividend yield support.
First Citizens BancShares (FCNCA) trades at $2,068.39, down slightly by 0.15% with a bearish technical signal. The company demonstrates strong fundamentals with a P/E of 11.08 and net income margin of 25.23%, having beaten earnings estimates for three consecutive quarters. Recent business developments include branch acquisitions and new financing initiatives, while analyst consensus shows 82% hold ratings with a $2,290 price target.
FCNCA presents a mixed outlook with strong profitability metrics offset by bearish technical indicators. Investment opportunity lies in continued earnings outperformance and strategic expansion, while risks include negative cash flow trends and institutional selling pressure. The stock offers value characteristics but requires monitoring of technical support levels near $2,028.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About First Citizens BancShares Inc
First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.
Read more on FCNCA →
